The Her2/neu-targeted Ad effectively transduced Her2/neu-overexpressing cancer cells via a specific interaction between Herceptin immobilized on the surface of PEGylated oAd and Her2/neu expressed on the surface of cancer cells. The gene discussed is ERBB2; the disease is cancer.